
Malaria vaccine shows promise against relapsing form of the disease
12 July 2023
A vaccine induced an immune response against the malaria parasite Plasmodium vivax, which can remain dormant in the body and cause a relapse of symptoms

12 July 2023
A vaccine induced an immune response against the malaria parasite Plasmodium vivax, which can remain dormant in the body and cause a relapse of symptoms

10 July 2023
A gene-editing technique makes mosquitoes produce antibodies against the malaria parasite, which could mean cases in people are also slashed

27 June 2023
Five malaria cases have been reported in Florida and Texas, all of which were acquired through local transmission

7 May 2023
Many countries and territories have malaria-free status, however, this may be very difficult to achieve in parts of Africa where the parasite is endemic

13 April 2023
A malaria vaccine that is 77 per cent effective in clinical trials has been approved for use in children 3 to 5 years old, the group most vulnerable to dying from the disease

1 November 2022
A malaria outbreak in Ethiopia earlier this year has been linked to an invasive species of mosquito that can persist throughout the dry season, complicating the fight to prevent the insects’ spread

21 September 2022
Gene editing mosquitoes so they die before malaria parasites can develop inside them could stop the spread of the deadly parasite entirely, according to lab studies and computer models

21 September 2022
After being bitten by malaria-carrying mosquitoes, people with a certain mix of gut bacteria had much higher levels of the parasite in their blood than those with different microbes

20 September 2022
A fungal skin disease that caused amphibian numbers to plummet in Costa Rica and Panama lowered the number of amphibian tadpoles that were eating mosquito larvae, allowing the insects to flourish and spread malaria

24 August 2022
A "living vaccine" containing malaria parasites with key genes deleted has produced promising results in a small initial trial